Cerebrospinal Fluid Iron-Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease

Fabian Maass; Bernhard Michalke; Desiree Willkommen; Sezgi Canaslan; Matthias Schmitz; Mathias Bähr; Inga Zerr; Paul Lingor

doi:10.1002/mds.28790

Cerebrospinal Fluid Iron-Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease

Fabian Maass
, Bernhard Michalke
, Desiree Willkommen
, Sezgi Canaslan
, Matthias Schmitz
, Mathias Bähr
, Inga Zerr
, Paul Lingor

Department of Neurology

University Medical Center
Helmholtz Zentrum München German Research Center for Environmental Health
German Center for Neurodegenerative Diseases (DZNE)

Research output: Contribution to journal › Letter › peer-review

16 Scopus citations

Original language	English
Pages (from-to)	2967-2969
Number of pages	3
Journal	Movement Disorders
Volume	36
Issue number	12
DOIs	https://doi.org/10.1002/mds.28790
State	Published - Dec 2021

Access to Document

10.1002/mds.28790

Cite this

@article{d2d997203b13439f853f1ec382f147a1,

title = "Cerebrospinal Fluid Iron-Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease",

author = "Fabian Maass and Bernhard Michalke and Desiree Willkommen and Sezgi Canaslan and Matthias Schmitz and Mathias B{\"a}hr and Inga Zerr and Paul Lingor",

note = "Funding Information: FM received speaker honoraria from Bial. Paul Lingor is supported by the NUM research network, the Bavarian Staatsministerium f{\"u}r Wissenschaft und Kunst (StMWK), the Deutsche Forschungsgemeinschaft, the Bundesministerium f{\"u}r Bildung und Forschung (BMBF), the Deutsches Zentrum f{\"u}r Neurodegenerative Erkrankungen (DZNE), the Deutsche Gesellschaft f{\"u}r Muskelkranke, the Else Kr{\"o}ner Fresenius Stiftung and received consulting or speakers honoraria from AbbVie, Alexion, Bial, Desitin, ITF Pharma, Stadapharm. Funding Information: : This study was funded by DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB) (P.L., M.B.); Forschungskolleg TRANSMED G{\"o}ttingen, which was supported by the Ministerium f{\"u}r Wissenschaft und Kultur, Niedersachsen, Germany (F.M.). Funding agencies ",

year = "2021",

month = dec,

doi = "10.1002/mds.28790",

language = "English",

volume = "36",

pages = "2967--2969",

journal = "Movement Disorders",

issn = "0885-3185",

publisher = "John Wiley \& Sons Inc.",

number = "12",

}

TY - JOUR

T1 - Cerebrospinal Fluid Iron-Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease

AU - Maass, Fabian

AU - Michalke, Bernhard

AU - Willkommen, Desiree

AU - Canaslan, Sezgi

AU - Schmitz, Matthias

AU - Bähr, Mathias

AU - Zerr, Inga

AU - Lingor, Paul

N1 - Funding Information: FM received speaker honoraria from Bial. Paul Lingor is supported by the NUM research network, the Bavarian Staatsministerium für Wissenschaft und Kunst (StMWK), the Deutsche Forschungsgemeinschaft, the Bundesministerium für Bildung und Forschung (BMBF), the Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), the Deutsche Gesellschaft für Muskelkranke, the Else Kröner Fresenius Stiftung and received consulting or speakers honoraria from AbbVie, Alexion, Bial, Desitin, ITF Pharma, Stadapharm. Funding Information: : This study was funded by DFG Research Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB) (P.L., M.B.); Forschungskolleg TRANSMED Göttingen, which was supported by the Ministerium für Wissenschaft und Kultur, Niedersachsen, Germany (F.M.). Funding agencies

PY - 2021/12

Y1 - 2021/12

UR - https://www.scopus.com/pages/publications/85115427616

U2 - 10.1002/mds.28790

DO - 10.1002/mds.28790

M3 - Letter

C2 - 34553776

AN - SCOPUS:85115427616

SN - 0885-3185

VL - 36

SP - 2967

EP - 2969

JO - Movement Disorders

JF - Movement Disorders

IS - 12

ER -

Cerebrospinal Fluid Iron-Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease

Access to Document

Other files and links

Cite this